1 / 19

Health Strategy on HCV in The Netherlands

Health Strategy on HCV in The Netherlands. V H PB meeting May 200 2. van Hattum. Health Strategy on HCV in The Netherlands. V H PB meeting May 200 2. epidemiology observations recommendations. HCV in The Netherlands Epidemiology. HCV in The Netherlands Epidemiology.

zipporah-deleon
Download Presentation

Health Strategy on HCV in The Netherlands

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Health Strategy on HCVinThe Netherlands VHPB meetingMay 2002 van Hattum

  2. Health Strategy on HCVinThe Netherlands VHPB meetingMay 2002 • epidemiology • observations • recommendations

  3. HCV in The NetherlandsEpidemiology

  4. HCV in The NetherlandsEpidemiology • prevalence in the general population • new blood donors: 0.04 % • estimated in general population: 5-10x • blood donors 1984-1990: <0.2 % • general population (low risk profile):0.1 % • general population (extrapolated):<0.4 % HCV observed in “random” population: 0.3-0.4 %

  5. HCV in The NetherlandsEpidemiology • prevalence in recipients of blood products • haemophiliacs (81 %) 1150 • haemodialysis (2.7 %) 110 • blood transfusions (est.) 13500 • ~ 0.1 % of general population

  6. HCV in The NetherlandsEpidemiology • prevalence, other groups • ivd users (75 %) 12000 • allochtonous (1 - 2.5 %) <25000 • ~ 0.2 % of general population • hospital infection, needle stick, transplantation, dentist • household, perinatal, sexual, tattoo/piercing

  7. HCV in The NetherlandsEpidemiology prevalence General population HCV observed in “random” population: 0.3-0.4 % Risk groups recipients of blood products 0.1 % ivd users 0.08 % allochtonous 0.15 % risky behaviour <0.1 % + 0.4 % ~ 60 000 people, where are they ?

  8. HCV in The NetherlandsBasic Facts Minister of Health, Welfare and Sports Health Council of the Netherlands • chronic hepatitis C is a serious disease • hepatitis C virus can be detected with great accuracy • hep C is aggravated by hep A, hep B, HIV or alcohol • treatment is available and may result in elimination of • the HCV and cure

  9. HCV in The NetherlandsBasic Facts Minister of Health, Welfare and Sports Health Council of the Netherlands • overall prevalence is considered to be comparable to • other countries in Northern Europe • most prevalent risk groups: • people who have used intravenous drugs • recipients of blood products • allochtonous descent • general or focused screening programs to detect • sporadic HC patients seem inefficient

  10. HCV in The NetherlandsBasic Facts Minister of Health, Welfare and Sports Health Council of the Netherlands • HCV is transmitted mainly via blood or blood products • hygienic measures among non-regular practitioners • (tattoo, piercing, acupuncture, ritual) are unclear

  11. HCV in The NetherlandsBasic Facts Minister of Health, Welfare and Sport Health Council of the Netherlands • it is the patients’ right that physicians provide them • spontaneously with relevant information • the general population lacks adequate knowledge • about HCV, the transmission routes, the disease • and possible treatment • this prevents them from taking responsibility for their • own health

  12. HCV in The NetherlandsRecommendations Minister of Health, Welfare and Sport Health Council of the Netherlands • a general look back, i.e. tracing and testing all people • possibly at risk in the past would be inefficient • hospitals should keep precise records of the origin • and use of blood products • epidemiological research is required as to the • prevalence of HCV infection in the various population groups • children of HCV positive mothers • first generation of allochtonousdescent

  13. HCV in The NetherlandsRecommendations Minister of Health, Welfare and Sport Health Council of the Netherlands • tracing and treating patients with conditions that go • along with increased likelihood of HCV infection • haemophiliacs • haemodialysis patients • polytransfusees • patients with organ transplants • patients with puncture wounds • patients with hep C must be advised to stop alcohol

  14. HCV in The NetherlandsRecommendations Minister of Health, Welfare and Sport Health Council of the Netherlands • medical doctors of various disciplines must be • trained on diagnostics and advising patients • professionals involved in increased risk of HCV • transmission must be informed on hygiene • hairdressers • chiropodists • acupuncturists • piercing / tattoo practitioners • ritual practitioners

  15. HCV in The NetherlandsRecommendations Minister of Health, Welfare and Sport Health Council of the Netherlands • information to the general population • the disease • the transmission • the possibility to treat • goal-oriented information to people in risk groups • seek medical care • if necessary, receive treatment • Immigrants should be informed through their own channels • intermediaries should be trained for that purpose

  16. HCV in The Netherlands Hepatitis C Surveillance study 1999/2000 mixed population, 1.5 million, 1.5 year 78 new hepatitis C patients diagnosed 19 referred to internist / gastroenterologist 3 treated with IFN + ribavirin current situation • active awareness programs in risk groups • training courses to professionals • in cooperation with the various professional societies • special aspects concerning each professional group • aiming at hygienic measures • providing information to clients / patients • diagnosing new patients • providing treatment

  17. HCV in The Netherlands current situation HC treatment of (ex) i.v. drug users starting up nation wide pilot study: - feasible if using infrastructure of drug user control programs if the present staff is trained - good compliance IFN 6 months, 56 patients, 2 dropouts In NL most drug addicts are registered in programs everybody has a (mandatory) health insurance HC treatment (IFN+riba) is available and refundable • active awareness programs in risk groups • training courses to professionals • in cooperation with the various professional societies • special aspects concerning each professional group • aiming at hygienic measures • providing information to clients / patients • diagnosing new patients • providing treatment • special treatment programs of risk groups

  18. Health Strategy onHCV in The Netherlands summary • collect data on epidemiology and support research • improve the awareness of the disease and hygiene • general population • risk groups • improve recognition of the disease and hygiene • by non-medical practitioners • by medical professionals • improve treatment of the disease • stimulate referral: non-medical, general practitioner, specialist • stimulate adequate treatment by the specialists • support treatment programmes for risk groups

  19. Health Strategy on HCVinThe Netherlands VHPB meetingMay 2002 van Hattum end

More Related